The MagMa Study: Quantum Magnetocardiography in Non-Ischemic Cardiomyopathy

The preprint operates within the dominant paradigm of evidence-based medicine, specifically focusing on cardiology and diagnostic tools. It adheres to the established norms of clinical research, including hypothesis testing, statistical analysis, and comparison against existing gold standards.

The research presented in this preprint contributes to normal science by refining and validating a diagnostic tool (magnetocardiography or MCG) within the existing paradigm of cardiology. The study design, methodology, and interpretation of results align with established practices. The research aims to improve the accuracy and efficiency of diagnosing non-ischemic cardiomyopathy by validating the diagnostic capability of the T-beg-Tmax MCG score against existing gold standards (CMR, EMB and PET-CT). The focus is on incremental advancement within the current understanding of cardiomyopathy diagnosis, rather than proposing a radical shift in the fundamental approach. While the study introduces a novel application of MCG technology, it doesn't challenge existing diagnostic methods but aims to complement and potentially improve the diagnostic pathway. The preprint specifically mentions that "MCG is unlikely to replace established advanced imaging modalities such as CMR or FDG PET-CT." This further reinforces the classification of "normal science." It represents puzzle-solving activity within the existing framework, aiming to enhance current practices rather than overturning them.